Antiviral remdesivir prevents disease progression in monkeys with COVID-19
Wednesday, April 29, 2020 - 13:50
in Health & Medicine
Early treatment with the experimental antiviral drug remdesivir significantly reduced clinical disease and damage to the lungs of rhesus macaques infected with SARS-CoV-2, the coronavirus that causes COVID-19, according to National Institutes of Health scientists.